UK medicines export-restriction architecture
DHSC's standing regulation-43(2) (Human Medicines Regulations 2012) mechanism barring parallel export and hoarding of named medicines to protect domestic patient supply, revised on a rolling multi-times-per-year basis with MHRA licence-suspension enforcement. Distinct from the food-security export-control cluster (which targets staple-commodity price stabilisation via major-producer trade policy) — this is a single-country pharmaceutical-supply-security instrument, not a commodity-market intervention, and captures the ongoing addition/removal pattern rather than one-off shortage responses.
4 actionspeak severity 2· 1 sectors· 1 issuer· avg sev 1.8· span 7mo
No bilateral issuer→target vectors in this theme — likely a thematic cluster of domestic industrial-policy actions where the riposte forecast doesn’t apply (no cross-border counterparties).